国际妇产科学杂志 ›› 2019, Vol. 46 ›› Issue (4): 387-391.

• 论著 • 上一篇    下一篇

4种不同方案治疗绝经后萎缩性阴道炎疗效评价

迪丽努尔·吾布力,刘新莲,黄修菊,丁岩   

  1. 830054 新疆维吾尔自治区乌鲁木齐市,新疆医科大学第一附属医院妇科
  • 收稿日期:2019-01-10 修回日期:2019-03-20 出版日期:2019-08-15 发布日期:2019-08-15
  • 通讯作者: 丁岩,E-mail:ddy8930@126.com E-mail:ddy8930@126.com

The Efficacy of Four Different Therapies in Postmenopausal Atrophic Vaginitis

Dilinuer·wubuli,LIU Xin-lian,HUANG Xiu-ju,DING Yan   

  1. Department of Gynecology,The First Affiliated Hospital of Xinjiang Medical University,Urumqi 830054,China
  • Received:2019-01-10 Revised:2019-03-20 Published:2019-08-15 Online:2019-08-15
  • Contact: DING Yan,E-mail:ddy8930@126.com E-mail:ddy8930@126.com

摘要: 目的:比较绝经后女性萎缩性阴道炎4种不同治疗方案的疗效及安全性,以指导临床诊疗。方法:选取在2016年11月—2018年8月就诊于新疆医科大学第一附属医院门诊的120例萎缩性阴道炎绝经妇女,根据纳入、排除标准将研究对象随机分为非雌激素药物(重组人源胶原蛋白阴道凝胶,薇润)治疗组(A组),雌激素药物(结合雌激素乳膏,红丽来)治疗组(B组),雌激素药物联合局部抗炎药(红丽来+保妇康泡沫剂)治疗组(C组),以及非雌激素药物联合局部抗炎药(薇润+保妇康泡沫剂)治疗组(D组),比较4组的疗效及安全性。结果:治疗后,4组阴道症状和体征评分分别为(7.59±1.28)分、(6.76±1.33)分、(4.48±1.02)分和(5.34±1.01)分,即疗效C组>D组>B组>A组,差异均有统计学意义(均P<0.05);4组阴道pH值分别为5.10±0.15、4.38±0.17、4.04±0.18和4.24±0.13,即疗效C组>D组>B组>A组,差异均有统计学意义(均P<0.05);4组阴道细胞成熟评分分别为(31.94±3.16)分、(65.68±2.44)分、(72.19±2.86)分和(54.40±2.56)分,A组治疗前后差异无统计学意义(P>0.05),其余3组治疗后均较治疗前明显增高,且疗效C组>B组>D组,差异均有统计学意义(均P<0.05)。在治疗安全性方面,4组不同治疗方案的患者子宫内膜厚度、血清雌二醇(E2)、卵泡刺激素(FSH)和黄体生成激素(LH)水平,治疗前后差异无统计学意义(均P>0.05)。结论:4种治疗方案对萎缩性阴道炎都有明显疗效,若有激素治疗禁忌者及拒绝激素治疗者可以使用非雌激素类药物联合局部抗炎药物作为有效替代方案。

关键词: 萎缩性阴道炎, 治疗, 激素类, 雌激素类, 投药, 阴道内

Abstract: Objective: To compare the therapeutic efficacy and safety of four different options for postmenopausal atrophic vaginitis,to guide clinical diagnosis and treatment. Methods:120 cases of atrophic vaginitis in our department of gynecology from November 2016 to August 2018 were voluntarily enrolled according to the inclusion and exclusion criteria and randomly divided into four groups, which were group A(vaginal moisturiser without hormone:Weirun collagen vaginal gel), group B (Honglilai estrogens cream), group C (Honglilai estrogens cream + herbalanti-inflammatory agent: Baofukang froth) and group D (Weirun collagen vaginal gel + Baofukang froth). After the treatment, we made comparision of efficacy and safety among the four groups. Results:After the treatment,signs and symptoms scores off our groups are group A (7.59±1.28), group B (6.76±1.33), group C (4.48±1.02), group D (5.34±1.01), efficacy:group C>group D>group B>group A,and the difference was statistically significant (P<0.05). Vaginal pH results of four groups are group A (5.10±0.15), group B (4.38±0.17), group C (4.04±0.18), group D (4.24±0.13), efficacy:group C>group D>group B>group A,and the difference was statistically significant (P<0.05). MV results are group A (31.94±3.16), group B (65.68±2.44), group C (72.19±2.86), group D (54.40±2.56). MV of group A shows no statistical difference after the treatment (P>0.05), but the other three groups were significantly higher,efficacy:group C>group B>group D,and the difference was statistically significant(P<0.05). In terms of safety, plasma level of E2, FSH, LH and endometrial stripe show no significant difference (P>0.05). Conclusions:For patients who don′t want to or can′t take estrogen therapy, non-hormonal vaginal moisturisers and lubricants with local anti-inflammatory drugs can be an alternative choice.

Key words: Atrophic vaginitis, Therapy, Hormones, Estrogens, Administration, intravaginal

中图分类号: